256 related articles for article (PubMed ID: 25435026)
21. Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.
Kastrinaki MC; Pavlaki K; Batsali AK; Kouvidi E; Mavroudi I; Pontikoglou C; Papadaki HA
Clin Dev Immunol; 2013; 2013():265608. PubMed ID: 24386000
[TBL] [Abstract][Full Text] [Related]
22. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 1. Aplastic anemia].
Nakao S
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1882-90. PubMed ID: 22896990
[No Abstract] [Full Text] [Related]
23. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
24. Inherited bone marrow failure syndromes.
Collins J; Dokal I
Hematology; 2015 Aug; 20(7):433-4. PubMed ID: 26218202
[No Abstract] [Full Text] [Related]
25. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
26. [Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].
Kállay K; Csomor J; Ádám E; Bödör C; Kassa C; Simon R; Kovács G; Péter G; Ottóffy G; Bartyik K; Kiss C; Masát P; Réti M; Tóth B; Kriván G
Orv Hetil; 2018 Oct; 159(42):1710-1719. PubMed ID: 30334483
[TBL] [Abstract][Full Text] [Related]
27. [Gene mutations in bone marrow failure syndromes].
Yoshizato T; Makishima H
Rinsho Ketsueki; 2016; 57(12):2519-2525. PubMed ID: 28090021
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
29. Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): why hypercellular marrow strongly favors accelerated apoptosis.
Das M; Chaudhuri S; Law S
Biochem Cell Biol; 2013 Oct; 91(5):303-8. PubMed ID: 24032679
[TBL] [Abstract][Full Text] [Related]
30. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Makishima H
Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
[TBL] [Abstract][Full Text] [Related]
31. Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Selleri C; Serio B; Risitano AM
Mini Rev Med Chem; 2011 Jun; 11(6):536-43. PubMed ID: 21561402
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
33. Why is an energy metabolic defect the common outcome in BMFS?
Degan P; Ravera S; Cappelli E
Cell Cycle; 2016 Oct; 15(19):2571-2575. PubMed ID: 27579499
[TBL] [Abstract][Full Text] [Related]
34. [Exclusive diagnosis of aplastic anemia].
Wang HQ; Shao ZH
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(12):830-832. PubMed ID: 35330574
[TBL] [Abstract][Full Text] [Related]
35. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
[TBL] [Abstract][Full Text] [Related]
36. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
37. The diverse expression of the WT1 gene in patients with acquired bone marrow failure syndromes.
You Y; Huo J; Lu S; Shao Y; Ge M; Shi J; Li X; Huang J; Huang Z; Zhang J; Wang M; Nie N; Zheng Y
Leuk Lymphoma; 2018 Apr; 59(4):950-957. PubMed ID: 28728504
[TBL] [Abstract][Full Text] [Related]
38. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S
Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832
[TBL] [Abstract][Full Text] [Related]
39. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
[TBL] [Abstract][Full Text] [Related]
40. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]